Alzheimer’s study lacks ‘shock and awe’ Biogen investors sought Biogen shares dropped 8.4 percent as investors were hoping for a bigger breakthrough. July 27, 2018June 27, 2019 Wellness
Drugmakers call experimental Alzheimer’s drug study positive Biogen, Eisai shares jump on study news; too soon to say drug marks real advance, experts say. July 6, 2018June 27, 2019 Wellness
